Vasamed Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2001
2002
2003
2004
2005
Sales/Revenue
688.00
1,574.80
2,123.90
1,069.10
1,386.30
Cost of Goods Sold (COGS) incl. D&A
880.00
422.00
2,261.10
1,338.70
1,455.70
Gross Income
192.00
1,152.80
137.20
269.60
69.40
SG&A Expense
2,536.00
3,035.10
2,149.80
3,485.90
4,568.90
Unusual Expense
555.00
-
-
2,539.40
104.00
Non Operating Income/Expense
668.00
29.30
5.80
20.00
12.30
Interest Expense
786.00
0.40
-
147.00
158.10
Pretax Income
3,400.00
1,852.50
2,281.10
6,421.90
4,888.20
Consolidated Net Income
3,400.00
1,852.50
2,281.10
6,421.90
4,888.20
Net Income
3,400.00
1,852.50
2,281.10
6,421.90
4,888.20
Net Income After Extraordinaries
3,400.00
1,852.50
2,281.10
6,421.90
4,888.20
Net Income Available to Common
3,400.00
1,852.50
2,281.10
6,421.90
6,852.10
EPS (Basic)
2.22
0.67
0.71
1.85
1.84
Basic Shares Outstanding
1,516.20
2,746.70
3,192.10
3,472.30
3,717.70
EPS (Diluted)
2.24
0.67
0.71
1.85
1.84
Diluted Shares Outstanding
1,516.20
2,746.70
3,192.10
3,472.30
3,717.70
EBITDA
1,848.00
1,737.60
2,196.20
3,554.30
4,482.70
Non-Operating Interest Income
1.00
1.00
0.10
-
-
Preferred Dividends
-
-
-
-
1,963.90
About Vasamed
View Profile
